BICYCLIC-FUSED HETEROARYL OR ARYL COMPOUNDS AND THEIR USE AS IRAK4 INHIBITORS

Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula,as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment of autoimmune and inflammatory diseases associated with Inte...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DEHNHARDT Christoph Martin, WANG Xiaolun, HUANG Horng-Chih, PIERCE Betsy Susan, WRIGHT Stephen Wayne, LOVERING Frank Eldridge, ANDERSON David Randolph, HEPWORTH David, LEE Katherine Lin, PAPAIOANNOU Nikolaos, LEE Arthur, BUNNAGE Mark Edward, GOLDBERG Joel Adam, HAN Seungil, CURRAN Kevin Joseph, LOWE Michael Dennis, PATNY Akshay, STROHBACH Joseph Walter, GAVRIN Lori Krim, MATHIAS John Paul, ZAPF Christoph Wolfgang, TRZUPEK John David, VARGAS Richard, SAIAH Eddine
Format:	Patent
Sprache:	eng ; slv
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Compounds, tautomers and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula,as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment of autoimmune and inflammatory diseases associated with Interleukin-1 Receptor Associated Kinase (IRAK), methods of synthesis, and intermediates are also disclosed.